The role of GATA3-positive macrophages in cardiovascular pathologies
GATA3 阳性巨噬细胞在心血管病理中的作用
基本信息
- 批准号:10643888
- 负责人:
- 金额:$ 41.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Acute myocardial infarctionAffectAgonistAreaArterial Fatty StreakArterial InjuryAtherosclerosisAttenuatedBiological MarkersBone Marrow TransplantationCardiacCardiovascular DiseasesCardiovascular PathologyCardiovascular systemCaringCell Culture TechniquesCellsCholesterolClinicalClinical TrialsComplicationCost MeasuresDataDeveloping CountriesDevelopmentDiseaseDisease ProgressionEconomic BurdenEnvironmentEventExperimental ModelsFutureGATA3 geneGenetic TranscriptionGoalsHeartHeart DiseasesHeart failureHomeostasisHumanHuman ActivitiesHuman PathologyImmuneImmunologyIn VitroInfiltrationInflammationInflammatoryInjuryInterleukin-4InvestigationInvestigational TherapiesIschemic StrokeKnock-outKnowledgeLeft Ventricular RemodelingLeukocytesMacrophageMeasuresMediatingMusMyeloid CellsMyocardialMyocardial InfarctionMyocarditisMyocardiumNeutrophil InfiltrationOrganPathogenesisPathologyPathway interactionsPatientsPhenotypePlayProcessPublic HealthQualifyingRegulationReportingResearchRoleSignal PathwaySignal TransductionSiteT-LymphocyteTestingTherapeuticTimeTranslationsTransplantation Immunologycell typechronic inflammatory diseaseclinical practiceexperiencehealingheart functionimprovedin vivoinflammatory milieuinnovationinsightmonocytemortalitymouse modelmyocardial injurynovelnovel therapeutic interventionnovel therapeuticspre-clinicalpreventrecruitsingle cell technologytargeted treatmenttoolvascular inflammationviral myocarditis
项目摘要
PROJECT SUMMARY/ABSTRACT
Vascular inflammation is a key component of atherosclerosis that contributes to plaque instability and clinical
cardiovascular events, including ischemic stroke, and myocardial infarction (MI). Despite decades of research,
the immune mechanisms contributing to these processes remain largely unresolved. Among myeloid cells,
monocytes/macrophages are believed to be major players in the pathogenesis of cardiovascular diseases
(CVD). Emerging single-cell technologies have unveiled that the macrophage pool in CVD is vastly
heterogeneous, containing a plethora of transcriptionally distinct subpopulations. In chronic inflammatory
diseases, GATA3 is regarded as a master regulator of the phenotype of T-cells and other immune cells.
However, the role of GATA3 in the regulation of the phenotype of macrophages is completely unknown. For
the first time, we demonstrated that GATA3 was expressed in macrophages and GATA3+ macrophages
accumulated into the myocardium after acute MI and adversely affected the cardiac function. In fact, the
deficiency of GATA3+ macrophages led to a significant improvement of cardiac function after acute MI. Cell
culture studies revealed that IL-33 stimulated the expression of GATA3 in macrophages. Our long term goal is
to dissect the mechanism/s that regulates the phenotype and function of GATA3+ macrophages in CVD. Our
rationale is that by identifying the mechanism/s that control the phenotype of GATA3+ macrophages in the
setting of CVD will offer new therapeutic opportunities. In Specific Aim 1, we will utilize novel mouse models in
combination with transplant immunology to test the hypothesis that macrophage-specific IL-33R signaling
controls the recruitment and function of GATA3+ macrophages in CVD. Most studies aimed at characterizing
the phenotypes of human macrophages are performed in vitro; however, the relevance to the function of
macrophages in vivo is uncertain. The role of GATA3 signaling in the activity of human macrophages in vitro
and in vivo is completely unknown. We have generated macrophage-specific humanized GATA3 sufficient
mice as a novel preclinical platform to test the hypothesis that human GATA3 signaling controls the
phenotype/function of macrophages after acute MI in Specific Aim 2. In depth knowledge of atherosclerotic
plaques is a prerequisite to preventing and treating MI. We found that GATA3+ macrophages accumulated into
atherosclerotic plaques, and GATA3 expression in macrophages is stimulated by cholesterol crystals.
However, the function of GATA3+ macrophages in atherosclerosis is completely unknown. In Specific Aim 3,
we will use atheroma-prone mouse models in combination with bone marrow transplantation to test the
hypothesis that GATA3+ macrophage subset/s are atherogenic. The proposed research is innovative because
we will investigate the effect of GATA3+ macrophages in CVD, a heretofore-unexamined process.
项目概要/摘要
血管炎症是动脉粥样硬化的一个关键组成部分,导致斑块不稳定和临床症状
心血管事件,包括缺血性中风和心肌梗塞(MI)。尽管经过数十年的研究,
促成这些过程的免疫机制在很大程度上仍未得到解决。在骨髓细胞中,
单核细胞/巨噬细胞被认为是心血管疾病发病机制的主要参与者
(化学气相沉积)。新兴的单细胞技术揭示了 CVD 中的巨噬细胞池
异质的,包含大量转录上不同的亚群。在慢性炎症
在疾病中,GATA3 被认为是 T 细胞和其他免疫细胞表型的主要调节因子。
然而,GATA3 在巨噬细胞表型调节中的作用尚不清楚。为了
我们首次证明GATA3在巨噬细胞和GATA3+巨噬细胞中表达
急性心肌梗死后,这些物质会积聚到心肌中,对心功能产生不利影响。事实上,
GATA3+巨噬细胞的缺乏导致急性心肌梗死后心功能的显着改善。细胞
培养研究表明 IL-33 刺激巨噬细胞中 GATA3 的表达。我们的长期目标是
剖析调节 CVD 中 GATA3+ 巨噬细胞表型和功能的机制。我们的
基本原理是通过确定控制 GATA3+ 巨噬细胞表型的机制
CVD的设置将提供新的治疗机会。在具体目标 1 中,我们将利用新颖的小鼠模型
与移植免疫学相结合,检验巨噬细胞特异性 IL-33R 信号传导的假设
控制 CVD 中 GATA3+ 巨噬细胞的募集和功能。大多数研究旨在表征
人类巨噬细胞的表型是在体外进行的;然而,与功能的相关性
巨噬细胞在体内的情况是不确定的。 GATA3信号在体外人巨噬细胞活性中的作用
而体内则完全未知。我们已经生成了足够的巨噬细胞特异性人源化 GATA3
小鼠作为新的临床前平台来测试人类 GATA3 信号控制的假设
具体目标 2. 深入了解动脉粥样硬化急性心肌梗死后巨噬细胞的表型/功能
斑块是预防和治疗心肌梗死的先决条件。我们发现GATA3+巨噬细胞聚集成
动脉粥样硬化斑块和巨噬细胞中的 GATA3 表达受到胆固醇晶体的刺激。
然而,GATA3+巨噬细胞在动脉粥样硬化中的功能尚不清楚。在具体目标 3 中,
我们将使用易发生动脉粥样硬化的小鼠模型结合骨髓移植来测试
假设 GATA3+ 巨噬细胞亚群是致动脉粥样硬化的。拟议的研究具有创新性,因为
我们将研究 GATA3+ 巨噬细胞在 CVD 中的作用,这是一个迄今为止未经检验的过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Prediman Krishan Shah其他文献
Management of Aminotransferase Elevations Observed in a Phase 3 Study of Patients with Homozygous Familial Hypercholesterolemia Treated with Lomitapide
- DOI:
10.1016/j.jacl.2013.03.058 - 发表时间:
2013-05-01 - 期刊:
- 影响因子:
- 作者:
Marina Cuchel;Emma A. Meagher;Prediman Krishan Shah;LeAnne T. Bloedon;Daniel J. Rader; Phase 3 HoFH Lomitapide Study Investigators - 通讯作者:
Phase 3 HoFH Lomitapide Study Investigators
Multiple myocardial crypts on cardiac CT angiography in a symptomatic patient with troponin elevation
- DOI:
10.1016/j.ijcard.2011.01.020 - 发表时间:
2011-11-17 - 期刊:
- 影响因子:
- 作者:
Rine Nakanishi;Ronak Rajani;Haim Shmilovich;Prediman Krishan Shah;Daniel S. Berman - 通讯作者:
Daniel S. Berman
Apheresis Treatment did not Impact the Efficacy of Lomitapide in Patients with Homozygous Familial Hypercholesterolemia: Results from the Pivotal Phase†
- DOI:
10.1016/j.jacl.2013.03.095 - 发表时间:
2013-05-01 - 期刊:
- 影响因子:
- 作者:
Marina Cuchel;Emma A. Meagher;Prediman Krishan Shah;LeAnne T. Bloedon;Daniel J. Rader; Phase 3 HoFH Lomitapide Study Investigators - 通讯作者:
Phase 3 HoFH Lomitapide Study Investigators
Prediman Krishan Shah的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Prediman Krishan Shah', 18)}}的其他基金
A hypercholesterolemia-induced immunometabolite in atherosclerosis
高胆固醇血症诱导的动脉粥样硬化免疫代谢物
- 批准号:
10532799 - 财政年份:2021
- 资助金额:
$ 41.75万 - 项目类别:
A hypercholesterolemia-induced immunometabolite in atherosclerosis
高胆固醇血症诱导的动脉粥样硬化免疫代谢物
- 批准号:
10343505 - 财政年份:2021
- 资助金额:
$ 41.75万 - 项目类别:
AAV MEDIATED APO A1 GENE THERAPY FOR ATHEROSCLEROSIS
AAV 介导的 APO A1 基因治疗动脉粥样硬化
- 批准号:
6575135 - 财政年份:2002
- 资助金额:
$ 41.75万 - 项目类别:
AAV MEDIATED APO A1 GENE THERAPY FOR ATHEROSCLEROSIS
AAV 介导的 APO A1 基因治疗动脉粥样硬化
- 批准号:
6338900 - 财政年份:2000
- 资助金额:
$ 41.75万 - 项目类别:
AAV MEDIATED APO A1 GENE THERAPY FOR ATHEROSCLEROSIS
AAV 介导的 APO A1 基因治疗动脉粥样硬化
- 批准号:
6189142 - 财政年份:1999
- 资助金额:
$ 41.75万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 41.75万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 41.75万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 41.75万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 41.75万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 41.75万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 41.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 41.75万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 41.75万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 41.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 41.75万 - 项目类别:
Studentship














{{item.name}}会员




